This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Jan 20;34(4):403.

doi: 10.1016/j.vaccine.2015.03.007. Epub 2015 Mar 21.

Intussusception risk with 116E rotavirus vaccine in Vellore, South India

Jalaj Bajaj¹, Jacob M Puliyel²

Affiliations

PMID: 25800733
DOI: 10.1016/j.vaccine.2015.03.007

Comment

Intussusception risk with 116E rotavirus vaccine in Vellore, South India

Jalaj Bajaj et al. Vaccine. 2016.

. 2016 Jan 20;34(4):403.

doi: 10.1016/j.vaccine.2015.03.007. Epub 2015 Mar 21.

Authors

Jalaj Bajaj¹, Jacob M Puliyel²

Affiliations

¹ St. Stephens Hospital, Delhi, India.
² St. Stephens Hospital, Delhi, India. Electronic address: puliyel@gmail.com.

PMID: 25800733
DOI: 10.1016/j.vaccine.2015.03.007

No abstract available

PubMed Disclaimer

Comment on

Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India.
John J, Kawade A, Rongsen-Chandola T, Bavdekar A, Bhandari N, Taneja S, Antony K, Bhatnagar V, Gupta A, Kabra M, Kang G. John J, et al. Vaccine. 2014 Aug 11;32 Suppl 1:A104-9. doi: 10.1016/j.vaccine.2014.03.036. Vaccine. 2014. PMID: 25091662 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information